Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K(+) induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats
por: Escobar Maldonado, Angélica del Pilar.
Publicado: (2016)
AVANCE EN EL DISEÑO DE UN PÉPTIDO BLOQUEADOR DEL RECEPTOR OPIOIDE KAPPA 2 HUMANO
Se evaluó la posibilidad de predecir una probable estructura secundaria para el Receptor Opioide Kappa 2 humano tomando como base la secuencia de aminoácidos del Receptor Opioide Kappa 1 humano. La estructura predicha mostró ser compatible con los datos que se poseen acerca de este tipo de receptore...
Guardado en:
Ejemplares Similares
-
Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K(+) induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats
por: Escobar Maldonado, Angélica del Pilar.
Publicado: (2016) -
Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593
por: Fuentealba Evans, José Antonio.
Publicado: (2017) -
Repeated Treatment With the kappa-Opioid Agonist U-69593 Increases K+-Stimulated Dopamine Release in the Rat Medial Prefrontal Cortex
por: Fuentealba Evans, José Antonio.
Publicado: (2016) -
E-2078, a Potent, Selective & Stable Dynorphin Analog With Preferential Activity for the Kappa-Opioid Receptor Subtype on the Mouse Vas Deferens Neuroeffector Junction
por: Huidobro-Toro, Juan Pablo.
Publicado: (2017) -
Repeated administration of the selective kappa‐opioid receptor agonist U‐69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens
por: Fuentealba Evans, José Antonio.
Publicado: (2017)